Fusimab

Business Data, Corporate Office and Headquarter Address

About

Fusimab is Biotechnology in Israel that focus on operator business. Founded in 2010. They cover business area such as operator, specific antibody, therapeutic, cancer patient.

Business Type

Biotechnology

Country

Israel

Founded

2010
( 14 years old in 2024 )

Company Focus

Operator

Website

-

Corporate Office and Headquarter Office address:

14 Shenkar Street
Herzeliya 46140
Israel

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

operatorspecific antibodytherapeuticcancer patient

* We use standard office opening hours in near Fusimab's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Fusimab Frequently Asked Questions

What or who is Fusimab?

Fusimab is Biotechnology business from Israel that founded in 2010 (14 years old in 2024), Fusimab business is focusing on Operator.

Where is Fusimab headquarter and corporate office address?

Fusimab headquarter office and corporate office address is located in 14 Shenkar Street Herzeliya 46140 Israel.

Where is Fusimab country origins?

Fusimab was founded in Israel.

What is Operator business focus on?

In 2024, Fusimab is currently focus on operator sector.

Operator Business Interest from Google Trend

Above is snippet of Google Trends for "operator" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Fusimab, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.